The rewarding effects of 3,4-methylenedioxy-metamphetamine (MDMA) have been demonstrated in conditioned place preference (CPP) procedures, but the involvement of the dopaminergic system in MDMA-induced CPP and reinstatement is poorly understood.In this study, the effects of the DA D1 antagonist SCH 23390 (0.125 and 0.250 mg/kg), the DA D2 antagonist Haloperidol (0.1 and 0.2 mg/kg), the D2 antagonist Raclopride (0.3 and 0.6 mg/kg) and the dopamine release inhibitor CGS 10746B (3 and 10 mg/kg) on the acquisition, expression and reinstatement of a CPP induced by 10 mg/kg of MDMA were evaluated in adolescent mice. As expected, MDMA significantly increased the time spent in the drug-paired compartment during the post-conditioning (Post-C) test, ...
The use of 3,4,methylenedioxymethamphetamine (MDMA), the active agent in ecstasy, during adolescence...
The use of 3,4,methylenedioxymethamphetamine (MDMA), the active agent in ecstasy, during adolescence...
Methylphenidate (MPH) (e.g., RitalinTM), prescriptions have significantly increased concomitant with...
The rewarding effects of 3,4-methylenedioxy-metamphetamine (MDMA) have been demonstrated in conditio...
Background: The rewarding effects of 3,4-methylenedioxy-metamphetamine (MDMA) have been demonstrated...
designed to characterize further the rewarding and aversive properties of 3,4-methylenedioxymethamph...
Adolescence represents a developmental period characterized by high vulnerability to drug consumptio...
International audienceThe amphetamine derivative 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) r...
International audienceThe amphetamine derivative 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) r...
International audienceThe amphetamine derivative 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) r...
The amphetamine derivative 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) reverses dopamine and s...
Rationale. ±3, 4-methelynedioxymethamphetamine (MDMA) is the primary psychoactive ingredient of the ...
Rationale. ±3, 4-methelynedioxymethamphetamine (MDMA) is the primary psychoactive ingredient of the ...
Rationale. ±3, 4-methelynedioxymethamphetamine (MDMA) is the primary psychoactive ingredient of the ...
Methylenedioxymethamphetamine (MDMA), a common recreational drug of abuse, possesses stimulant prope...
The use of 3,4,methylenedioxymethamphetamine (MDMA), the active agent in ecstasy, during adolescence...
The use of 3,4,methylenedioxymethamphetamine (MDMA), the active agent in ecstasy, during adolescence...
Methylphenidate (MPH) (e.g., RitalinTM), prescriptions have significantly increased concomitant with...
The rewarding effects of 3,4-methylenedioxy-metamphetamine (MDMA) have been demonstrated in conditio...
Background: The rewarding effects of 3,4-methylenedioxy-metamphetamine (MDMA) have been demonstrated...
designed to characterize further the rewarding and aversive properties of 3,4-methylenedioxymethamph...
Adolescence represents a developmental period characterized by high vulnerability to drug consumptio...
International audienceThe amphetamine derivative 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) r...
International audienceThe amphetamine derivative 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) r...
International audienceThe amphetamine derivative 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) r...
The amphetamine derivative 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) reverses dopamine and s...
Rationale. ±3, 4-methelynedioxymethamphetamine (MDMA) is the primary psychoactive ingredient of the ...
Rationale. ±3, 4-methelynedioxymethamphetamine (MDMA) is the primary psychoactive ingredient of the ...
Rationale. ±3, 4-methelynedioxymethamphetamine (MDMA) is the primary psychoactive ingredient of the ...
Methylenedioxymethamphetamine (MDMA), a common recreational drug of abuse, possesses stimulant prope...
The use of 3,4,methylenedioxymethamphetamine (MDMA), the active agent in ecstasy, during adolescence...
The use of 3,4,methylenedioxymethamphetamine (MDMA), the active agent in ecstasy, during adolescence...
Methylphenidate (MPH) (e.g., RitalinTM), prescriptions have significantly increased concomitant with...